Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantine Alifrangis

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
European Urology Focus|January 10, 2026
Subsequent-line Systemic Therapy for Metastatic or Recurrent Penile Cancer: A Systematic Review of Efficacy, Toxicity, and OutcomesRadion Garaz, Mahmoud Ziada, Jack Crozier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017
Chemical Profiling of Primary Mesothelioma Cultures Defines Subtypes with Different Expression Profiles and Clinical ResponsesLaurel M Schunselaar, Josine M M F Quispel-Janssen, Yongsoo Kim, et al.
Clinical Genitourinary Cancer|March 16, 2020
The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate CancerKatherine Smith, Myria Galazi, Mark R Openshaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysisConstantine Alifrangis, Roshan Agarwal, Delia Short, et al.
Anticancer Research|September 15, 2019
Somatic Transformation in Metastatic Testicular Germ Cell Tumours - A Different Disease EntityAnand Sharma, Constantine Alifrangis, Marina Milic, et al.
Nature Reviews. Urology|March 7, 2023
Treatment de-escalation for stage II seminomaGeorgina E Wood, Florence Chamberlain, Ben Tran, et al.
Prostate Cancer and Prostatic Diseases|July 26, 2020
Febrile neutropenia (FN) rates in metastatic hormone sensitive prostate cancer: the role of antibiotics as primary prophylaxisLara Pemberton, Kenrick Ng, Ursula McGovern, et al.
European Urology Focus|May 9, 2020
Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and SurgeryConstantine Alifrangis, Olivia Lucas, Sarah Benafif, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 25, 2026
Early Detection of Ototoxicity Using Serial Mobile Audiometry, Otoacoustic Emissions Testing, and Inner Ear Biomarker Measurement in Patients Receiving Platinum-Based Chemotherapy Treatment: It is Feasible to Implement in a National Health Service (NHS) Cancer Ambulatory Care SettingNishchay Mehta, Asma Awad, Marina Forbes, et al.
Clinical Genitourinary Cancer|December 3, 2025
GAMMA: Results from a Phase II Study for Relapsed Germ Cell Tumors using an Oxaliplatin-Based Treatment RegimenKenrick Ng, Garima Priyadarshini, Aaron Prendergast, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
European Urology Focus|January 10, 2026
Subsequent-line Systemic Therapy for Metastatic or Recurrent Penile Cancer: A Systematic Review of Efficacy, Toxicity, and OutcomesRadion Garaz, Mahmoud Ziada, Jack Crozier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2017
Chemical Profiling of Primary Mesothelioma Cultures Defines Subtypes with Different Expression Profiles and Clinical ResponsesLaurel M Schunselaar, Josine M M F Quispel-Janssen, Yongsoo Kim, et al.
Clinical Genitourinary Cancer|March 16, 2020
The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate CancerKatherine Smith, Myria Galazi, Mark R Openshaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysisConstantine Alifrangis, Roshan Agarwal, Delia Short, et al.
Anticancer Research|September 15, 2019
Somatic Transformation in Metastatic Testicular Germ Cell Tumours - A Different Disease EntityAnand Sharma, Constantine Alifrangis, Marina Milic, et al.
Nature Reviews. Urology|March 7, 2023
Treatment de-escalation for stage II seminomaGeorgina E Wood, Florence Chamberlain, Ben Tran, et al.
Prostate Cancer and Prostatic Diseases|July 26, 2020
Febrile neutropenia (FN) rates in metastatic hormone sensitive prostate cancer: the role of antibiotics as primary prophylaxisLara Pemberton, Kenrick Ng, Ursula McGovern, et al.
European Urology Focus|May 9, 2020
Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and SurgeryConstantine Alifrangis, Olivia Lucas, Sarah Benafif, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 25, 2026
Early Detection of Ototoxicity Using Serial Mobile Audiometry, Otoacoustic Emissions Testing, and Inner Ear Biomarker Measurement in Patients Receiving Platinum-Based Chemotherapy Treatment: It is Feasible to Implement in a National Health Service (NHS) Cancer Ambulatory Care SettingNishchay Mehta, Asma Awad, Marina Forbes, et al.
Clinical Genitourinary Cancer|December 3, 2025
GAMMA: Results from a Phase II Study for Relapsed Germ Cell Tumors using an Oxaliplatin-Based Treatment RegimenKenrick Ng, Garima Priyadarshini, Aaron Prendergast, et al.
Pageof 6